OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Zhe Liu, Neha Parveen, Urushi Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Gold nanoparticles and gold nanorods in the landscape of cancer therapy
Prashant Kesharwani, Ruiyang Ma, Liang Sang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 136

Emerging application of magnetic nanoparticles for breast cancer therapy
Tenzin Tsering Dongsar, Tenzin Sonam Dongsar, Mohammed A. S. Abourehab, et al.
European Polymer Journal (2023) Vol. 187, pp. 111898-111898
Closed Access | Times Cited: 60

Engineering siRNA therapeutics: challenges and strategies
Syed Saqib Ali Zaidi, Faria Fatima, Syed Aqib Ali Zaidi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 58

Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazim Nasir, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123276-123276
Closed Access | Times Cited: 43

New opportunities for RGD-engineered metal nanoparticles in cancer
Qin Wei, Jyoti Chandra, Mohammed A. S. Abourehab, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38

Designing Multivalent Aptamers: Recent Advancements in Diagnostic and Therapeutic Approaches for Cancer Treatment
Zahra Moradi, Khalil Abnous, Seyed Mohammad Taghdisi, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106614-106614
Closed Access | Times Cited: 1

Energy Metabolism and Stemness and the Role of Lauric Acid in Reversing 5-Fluorouracil Resistance in Colorectal Cancer Cells
Rina Fujiwara‐Tani, Yi Luo, Ruiko Ogata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 664-664
Open Access | Times Cited: 1

Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1

Nanotechnology-empowered strategies in treatment of skin cancer
Jyoti Chandra, Nazeer Hasan, Nazim Nasir, et al.
Environmental Research (2023) Vol. 235, pp. 116649-116649
Closed Access | Times Cited: 38

Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Houman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9529-9543
Closed Access | Times Cited: 29

Self-nanoemulsifying drug delivery system for pancreatic cancer
Neha Parveen, Afsana Sheikh, Mohammed A. S. Abourehab, et al.
European Polymer Journal (2023) Vol. 190, pp. 111993-111993
Closed Access | Times Cited: 27

The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 24

Understanding the theranostic potential of quantum dots in cancer management
Mohammad Sameer Khan, Afsana Sheikh, Mohammed A. S. Abourehab, et al.
Materials Today Communications (2023) Vol. 36, pp. 106424-106424
Closed Access | Times Cited: 21

Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy
Afsana Sheikh, Mohammed A. S. Abourehab, Alaa S. Tulbah, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104745-104745
Closed Access | Times Cited: 21

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Waleed Hassan Almalki, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103819-103819
Closed Access | Times Cited: 21

Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy
Afsana Sheikh, Prashant Kesharwani, Waleed Hassan Almalki, et al.
Nano-Micro Letters (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8

Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment
Lingxi Jiang, Qi Yao, Lei Yang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 5, pp. 100852-100852
Open Access | Times Cited: 15

PLGA nanomedical consignation: A novel approach for the management of prostate cancer
Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Garima Gupta, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123808-123808
Closed Access | Times Cited: 6

Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer
Yuanyuan Liu, Fengyang He, Longming Chen, et al.
Small (2024)
Closed Access | Times Cited: 5

The pharmacology, toxicology, and detoxification of Aconitum kusnezoffii Reichb., traditional and modern views
Kenneth Happy, Sungyu Yang, Chang-Ho Kang, et al.
Applied Biological Chemistry (2025) Vol. 68, Iss. 1
Open Access

Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies
Fauziya, Akash Gupta, Arif Nadaf, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 12

Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics
Sristi, Waleed Hassan Almalki, Ritu Karwasra, et al.
Progress in molecular biology and translational science (2024), pp. 219-248
Closed Access | Times Cited: 4

Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Liangliang Wang, Wei Si, Xianbin Yu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 24
Open Access | Times Cited: 10

Scouting the efficacy of targeted gold nanoparticles in the landscape of cancer therapy
Mahak Fatima, Garima Gupta, Swaranjeet Arora, et al.
European Polymer Journal (2024) Vol. 209, pp. 112924-112924
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top